| Identification | Back Directory | [Name]
Raltegravir Diketo Methoxy Impurity | [CAS]
518048-04-9 | [Synonyms]
Raltegravir Impurity 7
Raltegravir Impurity 12
Raltegravir Diketo Methoxy Impurity
Methyl [[1-[4-[[(4-Fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]- | [Molecular Formula]
C19H21FN4O6 | [MOL File]
518048-04-9.mol | [Molecular Weight]
420.39 |
| Chemical Properties | Back Directory | [density ]
1.38±0.1 g/cm3(Predicted) | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
4.50±1.00(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
Methyl [[1-[4-[[(4-Fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]amino](oxo)acetate is an intermediate in the synthesis of 2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) 2-(2-Amino-2-oxoacetic Acid) Raltegravir (D293105), which is a derivative of Raltegravir (R100300), a potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. |
|
|